EDINBURGH, Scotland, Oct. 3, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP) (NASDAQ:TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced that management will be presenting at the Dawson James 7th Annual Small Cap Growth Conference and LD MICRO Main Event XV.
Read more at prnewswire.comTC BioPharm to Present at Upcoming Investor Conferences
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here